Sa Eyes Records2013.metromobility

Sharon Anderson filed Complaints with www.bmp.state.mn.us Unabated via Attorney General Lori Swanson as Sharon is now Blind in Left Eye due to Medical Malpractice of Dr. Diane Tanabe of Lufkin Clinic, who did Laser Surgery when not needed, Gets the Public addicted to Eye Drops that are Dangerous and Costly ie; tRAVATON etc. www.sharon4mnag.blogspot.com
View more...
   EMBED

Share

Preview only show first 6 pages with water mark for full document please download

Transcript

Home MaiI Tasks My Account My Practices My Appointments My Medical Record Ìnbox Sent Ìtems Compose Message Request Appointment Request Health Record View Statements Research Center Account Settings My Ìnformation Manage User Grants Manage Practices Statement Notifications ©1996-2013 NextGen Healthcare Ìnformation Systems, Ìnc. This site best viewed with ÌE 6.0+ and Firefox 2.0+. Home Ìnbox Sent Ìtems My Account Compose Message | Request Appointment | Request Health Record | View Statements Letter re: Steffen - Message From: Sharon L. Anderson To: Schwartz MD, Gary Sent: Sun 4/7/2013 1:33:35 AM GMT Please take LegalNotice via www.ag.state.mn.us Sun7Apr.2013 re Uof M Merger with Fairview/Sandford. FURTHER: Affiant Sharon Scarrella Anderson aka Peterson only saw Rene Pelteir Age 79 1 ti stated Cataract in L Eye Bifocals Ordered FREE Mar.8th Saw Dr. Tom Rice St.Paul Eye now CEO Grand Ave, was Scheduled for Surgery, did not have Transport 2nd Opinion Mar27 Diane Tanube Lufkin Clinic, Pressured Laser which wrecked L Eye, Ringing Ears, Com plaint filed Apr.www.bmp.state.mn.us Then Martha Wright apparantly your Superio r at the Uof M techinally a State Employee, Recycled the Eye Drops Cambigan without a Rece Feb. 2013 Dr. Tani, stated Ìnoperable, re: Tubbs and You, AT ALL TÌMES MATERÌAL NO PREOPT WAS TAKEN, SPECÌFÌCALLY BY DR. TANUBE, AFFÌANTS GOOD FAÌTH ÌS TO CHARGE DR. TANUBE WÌTH NEGLÌENCE, TO FORCE BLÌNDNESS ON SHARON ANDERSON. FURTHER: Affiants call to St.Paul Eye mandate's that Dr. Tom Rice oversee this Matter, Further Affiant Sayet not at this time except clarification of your Letter to Steffen is somewhat Vague,Misleading Puts the www.stpauleye.com at Risk Either Dr. Tom Rice was in Error or Tanube must be Criminally Charge for her without PreOpt of Affiants Physical Health. Affiant also sugested to Wright that the Cost of GTravaton, Allergic that Ma on a Test Basis, Affiant also has Mecury Fillings on the L upper Teeth for 50 years, Now Deaf in R. Ear, Blind in L Eye. /s/ Sharon Anderson [email protected] www.sharon4anderson.org www.sharon4mnag.blogspot.com Page 1 of 1 NextMD - Your Medical Home on the Web 4/11/2013 https://www.nextmd.com/Messages/ReadMessage1.aspx?Q÷7892B90F6EDCEC60410... Home MaiI Tasks My Account My Practices My Appointments My Medical Record Ìnbox Sent Ìtems Compose Message Request Appointment Request Health Record View Statements Research Center Account Settings My Ìnformation Manage User Grants Manage Practices Statement Notifications ©1996-2013 NextGen Healthcare Ìnformation Systems, Ìnc. This site best viewed with ÌE 6.0+ and Firefox 2.0+. Home Ìnbox Sent Ìtems My Account Compose Message | Request Appointment | Request Health Record | View Statements Medicare BiIIings - Message From: Sharon L. Anderson To: Schwartz MD, Gary Sent: Thu 4/11/2013 5:57:01 PM GMT Please Submit online Medicare Billings, so Ì can refer to Ramsey County for Payments. Thanking you in Advance Further Ìt may be apparant that Google Lufkin ie: Diane Tanube facebook and other is connected Soon Ì will pdf the Complaint filed against Tanube. Furher Affiant has Mecury Fillings Cha Cells apparantly destroyed Mar 28th,2012 Medical Billings are Relevant www.sharon4anderson.org www.facebook.com/sharon4anderson [email protected] tel 651-776-5835 PS Dr. Tani signed off 4 Metro Mobility, "but for" does not accept Debit Master Page 1 of 1 NextMD - Your Medical Home on the Web 4/11/2013 https://www.nextmd.com/Messages/ReadMessage1.aspx?Q÷E3FE7B629BC352FDEB... Home MaiI Tasks My Account My Practices My Appointments My Medical Record Ìnbox Sent Ìtems Compose Message Request Appointment Request Health Record View Statements Research Center Account Settings My Ìnformation Manage User Grants Manage Practices Statement Notifications ©1996-2013 NextGen Healthcare Ìnformation Systems, Ìnc. This site best viewed with ÌE 6.0+ and Firefox 2.0+. Home Ìnbox Sent Ìtems My Account Compose Message | Request Appointment | Request Health Record | View Statements RE: Medicare BiIIings - Message From: Kim Stigman To: Sharon Anderson Received: Thu 4/11/2013 7:14:08 PM GMT Attachments: 04112013160803967 Hi Sharon, Please find a copy of your statement. Lisa is also mailing you a copy. Thank you Kim --- Original message --- From: Sharon L. Anderson To: Schwartz MD, Gary Subject: Medicare Billings Sent: 4/11/2013 5:57:01 PM GMT Please Submit online Medicare Billings, so Ì can refer to Ramsey County for Payments. Thanking you in Advance Further Ìt may be apparant that Google Lufkin ie: Diane Tanube facebook and other is connected to Associated Eye Care, Soon Ì will pdf the Complaint filed against Tanube. Furher Affiant has Mecury Fillings Challenge Tanube's Laser Treatment as Brains Cells apparantly destroyed Mar 28th,2012 Medical Billings are Relevant www.sharon4anderson.org www.facebook.com/sharon4anderson [email protected] tel 651-776-5835 PS Dr. Tani signed off 4 Metro Mobility, "but for" Page 1 of 2 NextMD - Your Medical Home on the Web 4/11/2013 https://www.nextmd.com/Messages/ReadMessage1.aspx?Q÷86D24F31B2987E09536B... Page 2 of 2 NextMD - Your Medical Home on the Web 4/11/2013 https://www.nextmd.com/Messages/ReadMessage1.aspx?Q÷86D24F31B2987E09536B... Pseudoexfoliation syndrome Classification and external resources ICD-10 H40.1 (http://apps.who.int/classiIications/icd10/browse/2010/en#/H40.1) OMIM 177650 (http://omim.org/entry/177650) eMedicine article/1206366 (http://emedicine.medscape.com/article/1206366- overview) Contents Ŷ 1 History Ŷ 2 Symptoms Ŷ 3 Diagnosis Ŷ 4 Causes Ŷ 5 Prevalence Ŷ 6 Treatment Ŷ 7 Research Ŷ 8 Alternative names Ŷ 9 ReIerences Pseudoexfoliation syndrome From Wikipedia, the Iree encyclopedia Pseudoexfoliation syndrome, (other names: Exfoliation glaucoma, Pseudoexfoliation glaucoma, Pseudoexfoliation of the lens, Exfoliation svndrome) sometimes abbreviated as PEX, |1| is an agingrelated systemic disease maniIesting itselI primarily in the eyes which is characterized by the accumulation oI microscopic granular amyloid-like protein Iibers. |2| Its cause is unknown, although there is speculation that there may be a genetic basis. It is more prevalent in women than men, and in persons past the age oI seventy. Its prevalence in diIIerent human populations varies; Ior example, it is prevalent in Scandinavia. |2| The buildup oI protein clumps can block normal drainage oI the eye Iluid called the aqueous humor and can cause, in turn, a buildup oI pressure leading to glaucoma and loss oI vision. |3| As worldwide populations become older because oI shiIts in demography, PEX may become a matter oI greater concern. |4| History PseudoexIoliation syndrome (PEX) was Iirst described by an ophthalmologist Irom Finland named John Lindberg in 1917. |5||4| He built his own slit lamp to study the condition and reported "grey Ilakes on the lens capsule", as well as glaucoma in 50° oI the eyes, and an "increasing prevalence oI the condition with age." |6| Several decades later, an ocular pathologist named Georgiana Dvorak-Theobald suggested the term pseudoexIoliation to distinguish it Irom a similar ailment which sometimes aIIected glassblowers called true exfoliation syndrome. The latter ailment is caused by heat or "inIrared- related changes in the anterior lens capsule" and is characterized by "lamellar delamination oI the lens capsule." |4| Sometimes the two terms "pseudoexIoliation" and "true exIoliation" are used interchangeably |6| but the more precise usage is to treat each case separately. Symptoms Page 1 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome Dr. Lindberg in 1917 built his own slit lamp to study pseudoexIoliation syndrome. A slit lamp in an ophthalmology clinic in recent times. Patients may have no speciIic symptoms. |4| In some cases, patients may complain oI lessened visual acuity or changes in their perceived visual Iield, and such changes may be secondary to or diIIerent Irom symptoms normally associated with cataracts or glaucoma. |4| PEX is characterized by tiny microscopic white |5| or grey |6| granular Ilakes |4| which are clumps oI proteins within the eye which look somewhat like dandruII when seen through a microscope and which are released by cells. |7| The abnormal |8| Ilakes, sometimes compared to amyloid-like material, |4||2| are visible during an examination oI the lens oI an eye by an ophthalmologist or optometrist, which is the usual diagnosis. |7| The white IluIIy material is seen in many tissues both ocular and extraocular: |8| in the anterior chamber structures, |4||5| trabecular meshwork, central disc, zonular Iibres, anterior hyaloid membrane, pupillary and anterior iris, trabecula, and occasionally the cornea. |9||10| The Ilakes are widespread. |8| One report suggested that the granular Ilakes were Irom abnormalities oI the basement membrane in epithelial cells, and that they were distributed widely throughout the body and not just within structures oI the eye. |4| There is some research suggesting that the material may be produced in the iris pigment epithelium, ciliary epithelium, or the peripheral anterior lens epithelium. |4| A similar report suggests that the proteins come Irom the lens, iris, and other parts oI the eye. |3| A report in 2010 Iound indications oI an abnormal ocular surIace in PEX patients, discovered by an eye staining method known as rose bengal. |11| PEX can become problematic when the Ilakes become enmeshed in a "spongy area" known as the trabecular meshwork and block its normal Iunctioning, |2| and may interact with degenerative changes in the Schlemm's canal and the juxtacanalicular area. |4| The blockage leads to greater-than- normal elevated intraocular pressure |2| which, in turn, can damage the optic nerve. |7| The eye produces a clear Iluid called the aqueous humor which subsequently drains such that there is a constant level oI saIe pressure within the eye, but glaucoma can result iI this normal outIlow oI Iluid is blocked. |7| Glaucoma is an umbrella term indicating ailments which damage Page 2 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome Diagram oI the eye. a ÷ optic nerve; b ÷ optic disc; c ÷ sclera; d ÷ choroid; e ÷ retina; I ÷ zonular Iibres; g ÷ posterior chamber; h ÷ iris; i ÷ pupil; j ÷ cornea; k ÷ anterior chamber (Iilled with aqueous humour); l ÷ ciliary muscle; m ÷ lens; n ÷ suspensory ligament; o ÷ vitreous humour; p ÷ Iovea the neural cable Irom the eye to the brain called the optic nerve, and which can lead to a loss oI vision. |7| In most cases oI glaucoma, typically called primarv open-angle glaucoma, the outIlow does not happen normally but doctors can not see what is causing the blockage; with PEX, however, the Ilakes are believed to be a cause oI the blockage. |7| PEX Ilakes by themselves do not directly cause glaucoma, but can cause glaucoma indirectly by blocking the outIlow oI aqueous humor, which leads to higher intraocular pressure, and this can cause glaucoma. |4| PEX has been known to cause a weakening oI structures within the eye which help hold the eye's lens in place, called lens zonules. |2| Diagnosis PEX is usually diagnosed by an eye doctor who examines the eye using a microscope. The method is termed slit lamp examination and it is done with an "85° sensitivity rate and a 100° speciIicity rate." |4| Since the symptom oI increased pressure within the eye is generally painless until the condition becomes rather advanced, it is possible Ior people aIIlicted with glaucoma to be in danger yet not be aware oI it. |7| As a result, it is recommended that persons have regular eye examinations to have their levels oI intraocular pressure measured, so that treatments can be prescribed beIore there is any serious damage to the optic nerve and subsequent loss oI vision. |7| Causes The cause or etiology oI pseudoexIoliation glaucoma is generally unknown. |7||4||2| PEX is generally believed to be a systemic disorder, |4||6||2| possibly oI the basement membrane oI the eye. |2| Researchers have noticed deposits oI PEX material in various parts oI the body, including in the skin, heart, lungs, liver, kidneys, and elsewhere. |6| Nevertheless, what is puzzling is that PEX tends to happen in only one eye Iirst, which scientists call unilateralitv, |2| and in some cases, gradually aIIlicts the other eye, which is termed bilateralitv. |9||4| According to this reasoning, iI PEX were a systemic disorder, then both eyes should be aIIected at the same time, but they are not. |9| There are contrasting reports about the extent and speed with which PEX moves Irom one eye to both eyes. According to one report, PEX develops in the second eye in 40° oI cases. |4| A contrasting report was that PEX can be Page 3 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome Iound in both eyes in almost all situations iI an electron microscope is used to examine the second eye, or iI a biopsy oI the conjunctiva was done, but that the extent oI PEX is the second eye was much less than the Iirst one. |4| A diIIerent report suggested that two thirds oI PEX patients had Ilakes in only one eye. |12||9| In one long term study, patients with PEX in only one eye were studied, and it was Iound that over time, 13° progressed to having both eyes aIIlicted by PEX. |9| Scientists believe that elevated levels oI plasma homocysteine are a risk Iactor Ior cardiovascular disease, |4| and two studies have Iound higher levels oI plasma homocysteine in PEX patients, |13| or elevated homocysteine concentrations in tear Iluids produced by the eye. |14| There is speculation that PEX may be caused by oxidative damage and the presence oI free radicals, although the exact nature oI how this might happen is still under study. |4| Studies oI PEX patients have Iound a decrease in the concentrations oI ascorbic acid, |15| increase in concentrations oI malondialdehyde, |16| and an increase in concentrations oI 8-iso-prostaglandinF2a. |17| There is speculation that genetics may play a role in PEX. |4||6| A predisposition to develop PEX later in liIe may be an inherited characteristic, according to one account. |4| One report suggested the genetic component was "strong". |1| One study perIormed in Iceland and Sweden has associated PEX with polymorphisms in gene LOXL1. |5| A report suggested that a speciIic gene named LOXL1 which was a member oI the Iamily oI enzymes which play a role in the linking oI collagen and elastin inside cells. LOXL1 was responsible Ior "all the heritability" oI PEX, according to one source. |6| Two distinct mutations in which a single nucleotide was changed, or called a single nucleotide polvmorphism or SNP, was discovered in Scandinavian populations and conIirmed in other populations, and may be involved with the onset oI PEX. |6| The gene is called LOXL1 ... Because pseudoexIoliation syndrome is associated with abnormalities oI the extracellular matrix and the basement membrane, this gene could reasonably play a role in the pathophysiology oI the condition. Dr. Allingham |6| Researchers are investigating whether Iactors such as exposure to ultraviolet light, living in northern latitudes, or altitude inIluence the onset oI PEX. |4| One report suggested that climate was not a Iactor related to PEX. |4| Another report suggested a possible link to sunlight as well as a possible autoimmune response, or possibly a virus. |1| Prevalence Scientists are studying diIIerent populations and relationships to try to learn more about the disease. They have Iound associations with diIIerent groups but it is not yet clear what the underlying Iactors are and how they aIIect diIIerent peoples around the world. Ŷ Glaucoma patients. While PEX and glaucoma are believed to be related, there are cases oI persons with PEX without glaucoma, and persons with glaucoma without PEX. |4| Generally, a person with PEX is considered as having a risk oI developing glaucoma, and vice versa. One study suggested that the PEX was present in 12° oI glaucoma patients. |4||18| Another Iound that PEX was present in 6° oI an "open-angle glaucoma" group. |19| PseudoexIoliation syndrome is Page 4 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome PEX is more prevalent in regions such as Scandinavia but it is not clearly understood why this is the case. In picture: a scene Irom western Norway. considered to be the most common oI identiIiable causes oI glaucoma. |5| II PEX is diagnosed without glaucoma, there is a high risk oI a patient subsequently developing glaucoma. |3| Ŷ Country and region. Prevalence oI PEX varies by geography. In Europe, diIIering levels oI PEX were Iound; 5° in England, 6° in Norway, 4° in Germany, 1° in Greece, and 6° in France. |4| One contrary report suggested that levels oI PEX were higher among Greek people. |20| One study oI a county in Minnesota Iound that the prevalence oI PEX was 25.9 cases per 100,000 people. |21| It is reportedly high in northern European countries such as Norway, Sweden and Finland, |2| as well as among the Sami people oI northern Europe, and high among Arabic populations, |22||23| but relatively rare among AIrican Americans and Eskimos. In southern AIrica, prevalence was Iound to be 19° oI patients in a glaucoma clinic attending to persons oI the Bantu tribes. |24| Ŷ Race. It varies considerably according to race. |4| Ŷ Gender. It aIIects women more than men. One report was that women were three times more likely than men to develop PEX. |4||25| Ŷ Age. Older persons are more likely to develop PEX. |4||2| And persons younger than 50 are highly unlikely to have PEX. A study in Norway Iound that the prevalence oI PEX oI persons aged 50 59 was 0.4° while it was 7.9° Ior persons aged 8089 years. |26| II a person is going to develop PEX, the average age in which this will happen is between 69 to 75 years, according to the Norwegian study. |4| A second corroborating report suggested that it happens primarily to people 70 and older. |2| While older people are more likely to develop PEX, it is not seen as a "normal" part oI aging. |4| Ŷ Other diseases. Sometimes PEX is associated with the development oI medical problems other than merely glaucoma. There are conIlicting reports about whether PEX is associated with problems oI the heart or brain; one study suggested no correlations |27| while other studies Iound statistical links with Alzheimer's disease, senile dementia, cerebral atrophy, chronic cerebral ischemia, stroke, transient ischemic attacks, heart disease, and hearing loss. |4| Treatment While PEX itselI is untreatable as oI 2011, it is possible Ior doctors to minimize the damage to vision and to the optic nerves by the same medical techniques used to prevent glaucoma. Ŷ Eyedrops. This is usually the Iirst treatment method. Eyedrops can help reduce intraocular pressure within the Page 5 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome Conventional surgery to treat glaucoma makes a new opening in the meshwork. This new opening helps Iluid to leave the eye and lowers intraocular pressure. In a surgical procedure called trabectome, the trabecular meshwork is removed to help glaucoma patients. eye. |7| The medications within the eyedrops can include beta blockers (such as levobunolol or timolol) which slow the production oI the aqueous humor. |7| And other medications can increase its outIlow, such as prostaglandin analogues (e.g. latanoprost). |7| And these medicines can be used in various combinations. |7| In most cases oI glaucoma, eyedrops alone will suIIice to solve the problem. Ŷ Laser surgery. A Iurther treatment is a type oI laser therapy known as trabeculoplasty in which a high-energy laser beam is pointed at the trabecular meshwork to cause it to "remodel and open" and improve the outIlows oI the aqueous humor. These can be done as an outpatient procedure and take less than twenty minutes. One report suggests this procedure is usually eIIective. |2| Ŷ Eye surgery. Surgery is the treatment method oI last resort iI the other methods have not worked. It is usually eIIective at preventing glaucoma. |2| Eye surgery on PEX patients can be subject to medical complications iI the Iibers which hold the lens have become weakened because oI a buildup Irom the Ilakes; iI the lens-holding Iibers have weakened, then the lens may become loose, and complications Irom eye surgery may result. |7| In such cases, it is recommended that surgeons act quickly to repair the phacodonesis beIore the lenses have dropped. |28| A surgeon cuts an opening in the white portion oI the eye known as the sclera, and removes a tiny area oI the trabecular meshwork which enables the aqueous humor to discharge. |7| This lowers the internal pressure within the eye and lessens the chance oI Iuture damage to the optic nerve. |7| Cases with pseudophacodonesis and dislocated IOL have been increasing in number, according to one report. |28| In cataract surgery, complications resulting Irom PEX include capsular rupture and vitreous loss. |2| Ŷ Drug therapy. There are speculations that iI genetics plays a role in PEX, and iI the speciIic genes involved can be identiIied, that possibly drugs can be developed to counteract these mutations or their eIIects. |6| But such drugs have not been developed as oI 2011. Patients should continue to have regular eye examinations so that physicians can monitor pressure levels and check whether medicines are working. Research Scientists and doctors are actively exploring how PEX happens, its causes, and how it might be prevented or mitigated. Research activity to explore what causes glaucoma has been characterized as "intense". |7| There has been research into the genetic basis oI PEX. One researcher speculated about a Page 6 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome possible "two-hit hypothesis" in which a single mutation in the LOXL1 gene puts people at risk Ior PEX, but that a second still-to-be-Iound mutation has some eIIect on the proteins, possibly aIIecting bonds between chemicals, such that the proteins are more likely to clump together and disrupt the outIlow oI aqueous humor. |6| Alternative names Ŷ ExIoliation glaucoma; XFG Ŷ PseudoexIoliation glaucoma Ŷ PseudoexIoliation oI the lens Ŷ ExIoliation syndrome; XFS References 1. ` D E F "Glaucoma In-Depth Report" (http://health.nytimes.com/health/guides/disease/glaucoma/print.html). The New York Times. 2011-07-09. Retrieved 2011-07-09. "PseudoexIoliation (PEX) syndrome ... The substance is composed oI proteins produced by the lens, iris, and other parts oI the eye. People can have this condition and not develop glaucoma, but they are at high risk." 2. ` D E F G H I J K L M N O P Q R S Yichieh Shiuey, MD (March 26, 1997). "Glaucoma Quiz 1" (http://www.djo.harvard.edu/print.php?url÷/physicians/kr/466&print÷1). Digital Journal of Ophthalmologv. Retrieved 2011-08-21. "... In Scandinavia, this condition represents greater than 50° oI all cases oI open angle glaucoma." 3. ` D E F "Glaucoma" (http://health.nytimes.com/health/guides/disease/glaucoma/causes.html). The New York Times. 2011-08-19. Retrieved 2011-08-19. "... PseudoexIoliation (PEX) syndrome (also known as exIoliation syndrome) is the most common identiIiable condition associated with glaucoma. The substance is composed oI proteins produced by the lens, iris, and other parts oI the eye." 4. ` D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] DD DE DF DG DH DI DJ Mauricio E Pons, MD; ChieI Editor: Hampton Roy Sr, MD; contributing authors: Babak Eliassi-Rad, MD; BradIord Shingleton, MD; Simon K Law, MD, PharmD (Aug 4, 2011). "PseudoexIoliation Glaucoma" (http://emedicine.medscape.com/article/1206366-overview). Medscape. Retrieved 2011-08-15. 5. ` D E F G H Damji, Karim F. (October 2007). "Progress in understanding pseudoexIoliation syndrome and pseudoexIoliation-associated glaucoma" (http://pubservices.nrc-cnrc.ca/rp-ps/absres.jsp?jcode÷cjo&Itl÷i07- 158&lang÷eng). Canadian Journal of Ophthalmologv 42 (5): 657658. doi:10.3129/I07-158 (http://dx.doi.org/10.3129°2FI07-158). PMID 17891191 (//www.ncbi.nlm.nih.gov/pubmed/17891191). Retrieved 2009-04-19. 6. ` D E F G H I J K L M N Tony Realini, M.D. "A new gene Ior pseudoexIoliation" (http://www.eyeworld.org/article.php?sid÷4670). EveWorld. Retrieved 2011-08-05. "A new gene deIect has been Iound that accounts Ior essentially all the heritability oI pseudoexIoliation syndrome." 7. ` D E F G H I J K L M N O P Q R S T Arthur J. Sit, MD, ophthalmology, Mayo Clinic, Rochester, Minn. (April 23, 2006). "Many types oI glaucoma, one kind oI damage to optic nerve" (http://articles.chicagotribune.com/2006-04-23/Ieatures/0604230427¸1¸aqueous-humor-glaucoma- optic-nerve). Chicago Tribune. Retrieved 2011-08-15. "Glaucoma ... Because elevated intraocular pressure (IOP) is the most important risk Iactor Ior glaucoma, most treatments are directed at lowering this pressure." 8. ` D E F N Demir, T Ulus, O E Yucel, E T Kumral, E Singar and H I Tanboga (June 24, 2011). Assessment of mvocardial ischaemia using tissue Doppler imaging in pseudoexfoliation svndrome (http://www.nature.com/eye/journal/vaop/ncurrent/Iull/eye2011145a.html). doi:10.1038/eye.2011.145 (http://dx.doi.org/10.1038°2Feye.2011.145). Retrieved 2011-08-15. Page 7 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome 9. ` D E F G H M Citirik, G Acaroglu, C Batman, L Yildiran and O Zilelioglu. A possible link between the pseudoexfoliation svndrome and coronarv arterv disease (http://www.nature.com/eye/journal/v21/n1/Iull/6702177a.html) 21 (1). doi:10.1038/sj.eye.6702177 (http://dx.doi.org/10.1038°2Fsj.eye.6702177). Retrieved 2011-08-15. 10. ^ Mizuno K, Murois S (1979). "Cycloscopy oI pseudoexIoliation". Am J Ophthalmol 87 (4): 513. PMID 443315 (//www.ncbi.nlm.nih.gov/pubmed/443315). 11. ^ "Data Irom E. Viso and colleagues advance knowledge in exIoliation syndrome epidemiology." Biotech Week. NewsRX. 2010. 12 Sep. 2012, Highbeam Research article (http://www.highbeam.com/doc/1G1- 224605737.html) Quote÷An abnormal ocular surIace detected by rose bengal staining is highly prevalent among subjects with pseudoexIoliation. 12. ^ Henry JC, Kruptin T, Schmitt M, LauIIer J, Miller E, Ewing MQ et al. (1987). "Long-term Iollow-up oI pseudoexIoliation and the development oI elevated intraocular pressure". Ophthalmologv 94 (5): 545552. PMID 3601370 (//www.ncbi.nlm.nih.gov/pubmed/3601370). 13. ^ Vessani RM, Ritch R, Liebmann JM, JoIe M (2003). "Plasma homocysteine is elevated in patients with exIoliation syndrome". Am J Ophthalmol 136 (1): 416. PMID 12834668 (//www.ncbi.nlm.nih.gov/pubmed/12834668). 14. ^ Roedl JB, Bleich S, Reulbach U, Rejdak R, Kornhuber J, Kruse FE et al. (2007). "Homocysteine in tear Iluid oI patients with pseudoexIoliation glaucoma". J Glaucoma 16 (2): 2349. doi:10.1097/IJG.0b013e31802d6942 (http://dx.doi.org/10.1097°2FIJG.0b013e31802d6942). PMID 17473737 (//www.ncbi.nlm.nih.gov/pubmed/17473737). 15. ^ Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, BuIidis T, Georgiadis N, Ringvold A (December 2002). "Ascorbic acid concentration is reduced in the aqueous humor oI patients with exIoliation syndrome". Am J Ophthalmol 134 (6): 87983. PMID 12470757 (//www.ncbi.nlm.nih.gov/pubmed/12470757). 16. ^ Yimaz A, Adiguzel U, Tamer L, Yildirim O, Oz O, Vatansever H (February 2005). "Serum oxidant/antioxidant balance in exIoliation syndrome". Clin Experiment Ophthalmol 33 (1): 636. doi:10.1111/j.1442-9071.2005.00944.x (http://dx.doi.org/10.1111°2Fj.1442-9071.2005.00944.x). PMID 15670081 (//www.ncbi.nlm.nih.gov/pubmed/15670081). 17. ^ Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Hollo G, Katsimbris IE, Georgiadis N. "8- Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour oI patients with exIoliation syndrome". Br J Ophthalmol 87 (3): 3536. doi:10.1136/bjo.87.3.353 (http://dx.doi.org/10.1136° 2Fbjo.87.3.353). 18. ^ Roth M, Epstein DL (1980). "ExIoliation syndrome". Am J Ophthalmol 89 (4): 47781. PMID 7369310 (//www.ncbi.nlm.nih.gov/pubmed/7369310). 19. ^ Cashwell LF Jr, Shields MB (1988). "ExIoliation syndrome in the southeastern United States. I. Prevalence in open-angle glaucoma and non-glaucoma populations". Acta Ophthalmol Suppl 184: 99102. PMID 2853929 (//www.ncbi.nlm.nih.gov/pubmed/2853929). 20. ^ "Greek population has higher prevalence oI pseudoexIoliation" (http://www.bioportIolio.com/news/article/617540/Greek-Population-Has-Higher- Prevalence-OI-PseudoexIoliation.html). BioPortfolio. April 15, 2011. Retrieved 2011-08-15. "PseudoexIoliation was Iound to be more prevalent in Greece than in other white populations," 21. ^ Karger RA, Jeng SM, Johnson DH, Hodge DO, Good MS (2003). "Estimated incidence oI pseudoexIoliation syndrome and pseudoexIoliation glaucoma in Olmsted County, Minnesota". J Glaucoma 12 (3): 1937. PMID 12782834 (//www.ncbi.nlm.nih.gov/pubmed/12782834). 22. ^ Summanen P, Tönjum AM (1988). "ExIoliation syndrome among Saudis". Acta Ophthalmol Suppl 184: 10711. PMID 2853905 (//www.ncbi.nlm.nih.gov/pubmed/2853905). 23. ^ Bialasiewicz AA, Wali U, Shenoy R, Al-Saeidi R (2005). "Patients with secondary open-angle glaucoma in pseudoexIoliation (PEX) syndrome among a population with high prevalence oI PEX. Clinical Iindings and morphological and surgical characteristics". Ophthalmologe 102 (11): 10648. doi:10.1007/s00347-005- 1226-2 (http://dx.doi.org/10.1007°2Fs00347-005-1226-2). PMID 15871021 (//www.ncbi.nlm.nih.gov/pubmed/15871021). 24. ^ Bartholomew RS (1973). "Pseudocapsular exIoliation in the Bantu oI South AIrica. II. Occurrence and prevalence" (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1214820). Br J Ophthalmol 57 (1): 415. PMC 1214820 (//www.ncbi.nlm.nih.gov/pmc/articles/PMC1214820). PMID 4705496 (//www.ncbi.nlm.nih.gov/pubmed/4705496). Page 8 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome 25. ^ Kozart DM, YanoII M (1982). "Intraocular pressure status in 100 consecutive patients with exIoliation syndrome". Ophthalmologv 89 (3): 2148. PMID 7088504 (//www.ncbi.nlm.nih.gov/pubmed/7088504). 26. ^ Aasved H (1971). "Mass screening Ior Iibrillopathia epitheliocapsularis, so-called senile exIoliation or pseudoexIoliation oI the anterior lens capsule". Acta Ophthalmol (Copenh). 49 (2): 33443. doi:10.1111/j.1755-3768.1971.tb00958.x (http://dx.doi.org/10.1111°2Fj.1755-3768.1971.tb00958.x). PMID 5109796 (//www.ncbi.nlm.nih.gov/pubmed/5109796). 27. ^ Shrum KR, Hattenhauer MG, Hodge D (2000). "Cardiovascular and cerebrovascular mortality associated with ocular pseudoexIoliation". Am J Ophthalmol 129 (1): 836. doi:10.1016/S0002-9394(99)00255-X (http://dx.doi.org/10.1016°2FS0002-9394°2899°2900255-X). PMID 10653417 (//www.ncbi.nlm.nih.gov/pubmed/10653417). 28. ` D E Rich Daly. "PseudoexIoliation syndrome`s surgical challenge" (http://www.eyeworld.org/article.php? sid÷2442&strict÷&morphologic÷&query÷implant). EveWorld. Retrieved 2011-08-21. "... Dr. Crandall urges surgeons to probe Ior such changes early because it is surgically much easier to repair the phacodonesis beIore the lenses have dropped." Retrieved Irom "http://en.wikipedia.org/w/index.php? title÷PseudoexIoliation¸syndrome&oldid÷543421276" Categories: Diseases oI the eye and adnexa Ŷ This page was last modiIied on 11 March 2013 at 13:35. Ŷ Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms oI Use and Privacy Policy. Wikipedia® is a registered trademark oI the Wikimedia Foundation, Inc., a non-proIit organization. Page 9 of 9 Pseudoexfoliation syndrome - Wikipedia, the free encyclopedia 4/15/2013 http://en.wikipedia.org/wiki/Pseudoexfoliation_syndrome *ODXFRPD DQG WKH %UDLQ 5HVHDUFKHUV QRZ YLHZ JODXFRPD DV D GLVHDVH RI WKH EUDLQ Å D QHXURGHJHQHUDWLYH GLVHDVH Å UDWKHU WKDQ VLPSO\ DQ H\H GLVHDVH 5HFHQW UHVHDUFK KDV VKRZQ WKDW WKH FRPSOH[ FRQQHFWLRQ EHWZHHQ WKH H\H DQG WKH EUDLQ LV DQ LPSRUWDQW NH\ WR WKH GLVHDVH Glaucoma shares a number of features with degenerative brain diseases such as Alzheimer's, Parkinson's, and Lou Gehrig's disease. Ìn all of these diseases, age and family history are significant risk factors, and specific areas of the brain are damaged over time. Ìn glaucoma, the only difference is that the "specific area of the brain¨ affected is the eye and optic nerve! Ìndeed the eye's retina and optic nerve are a part of the brain: during early development, a small part of the brain pouches out and becomes the retina and optic nerve. Ìnside the eye, a group of neurons called retinal ganglion cells collect all of the visual information and pass it down their extensions, called axons, through the optic nerve and back to the rest of the brain. The ganglion cell, which collects all the vision information from the other retinal cells, is the one type of cell that is initially damaged by glaucoma. The optic nerve continues to be a major focus for researching the underlying causes of glaucoma. Whether due to mechanical trauma, decreased blood flow, or other causes, optic nerve axon injury causes changes in retinal ganglion cells, eventually causing cell death. Researchers have observed that specific areas of injured optic nerve axons and retinal ganglion cell loss match the peripheral vision damage from glaucoma. Because the retinal ganglion cell axon stretches from the retina through the optic nerve to the brain, its surrounding cells also become damaged by glaucoma. Within the retina, other cells, such as amacrine cells, degenerate and rewire their connections after retinal ganglion cells are lost. There are also changes in the brain within the lateral geniculate nucleus (the main brain target of optic nerve axons), and even the visual cortex, which is the part of the brain that helps us interpret visual information. Page 1 of 2 Glaucoma and the Brain [ Glaucoma Research Foundation 6/22/2013 http://www.glaucoma.org/glaucoma/glaucoma-and-the-brain.php 251 Post Street, Suite 600 San Francisco, CA94108 (415) 986-3162 (800) 826-6693 Thus, in addition to treatments directed at lowering eye pressure, still the mainstay of glaucoma therapy, there may be opportunities to develop treatments directed at the retina and the brain. Some promising treatments that promote nerve health, called neurotrophic factors, could help at multiple places in the visual pathway. For example, neurotrophic factors such as ciliary neurotrophic factor (CNTF) may keep retinal ganglion cells from dying, a process called neuroprotection; they may increase axon regrowth down the optic nerve, called regeneration; and they may improve the support between the dying retinal ganglion cells and their surrounding cells in the retina and brain, called neuroenhancement. The understanding that one key to glaucoma is in the connections within the retina and to the brain has led to exciting advances in research that may well lead to new potential treatments. -- Article by Jeffrey L. Goldberg, MD, PhD, Associate Professor of Ophthalmology at the Bascom Palmer Eye Ìnstitute. Last reviewed on January 15, 2013 Glaucoma Research Foundation www.glaucoma.org This articIe appeared in the September 2010 issue of GIeams. Page 2 of 2 Glaucoma and the Brain [ Glaucoma Research Foundation 6/22/2013 http://www.glaucoma.org/glaucoma/glaucoma-and-the-brain.php Subj: UofM_Wright_Rice_Tanaube_Tani_Schwartz Date: 3/14/2013 4:25:20 P.M. Central Daylight Time From: [email protected] To: [email protected] CC: [email protected] Page 1 of 4 Thursday, March 14, 2013 AOL: Sharon4Anderson Thurs 14Mar2013 Request4Records in their Entirety of Sharon Anderson's Eye's How to Contact Dr. Tani Tani Eye Associates and CIinics 17 Exchange St W Suite 200 Saint PauI, MN 55102 (651) 227-8275 (Office) Fax 651-298-0160 Map & Directions · Affiant_CIient re: Your Recommendations GIacoma SpeciaIist Dr. PauI M. Tani, MD has admitting priviIeges at United HospitaI Records are Extensive Affiant gives Permission to Dr. Tani to request aII Records in this Matter from the Various Persons. TRANSPORTATION IS MAJOR ISSUE THEREFORE: Affiant Sharon Anderson aka Peterson_ScarreIIa caIIed Associated Eye Care re: CarI Tubbs http://www.associatedeyecare.com/ 280 Smith Ave N Suite 840 LocaI: 651-275-3000 Fax 651-275-3032 Contact Lisa Appt. Made with Gary S. Schwartz MD at the St. PauI Office Wed. 3Apr2013 DISCLAIMER: Tubbs does not go to St.PauI Office. ToII Free: 800-846-1877 LASIK: 888-466-2020 OpticaI: 651-275-3000 Saint PauI, MN 55102 Map & Directions : Carl B. Tubbs, M.D. SpeciaIties: Comprehensive Ophthalmology Glaucoma Surgery Cat aract Surgery Gary S. Schwartz, M.D. SpeciaIties: Comprehensive Ophthalmology Refractive Surgery Cataract Surgery Thomas J. Rice, MD (651)738-6500 or (800) 727-2279 Board-Certified OphthaImoIogist 'I enjoy the large range of ages of my patients and the positive impact on quality of life for my patients. I also enjoy the rapidly expanding technologies and positive patient interactions. I am open and compassionate, and I take time to relieve patients' fears and apprehensions. I believe eyecare should be fun for patients. I believe they should receive high-quality care and a sense of being taken care of. Seeing my patients become more at ease and no longer strictly focusing on their medical problems but more on the normal things in their lives is most gratifying for me." In his spare time, Dr. Rice enjoys spending time with his famiIy, hunting, outdoor sports, goIf, hockey and gourmet cooking (wiId game). Board-Certified :: American Board of OphthaImoIogy, LASIK-Certified, VISX®-Certified Residency :: OphthaImoIogy, University of Minnesota HospitaI and CIinics, MinneapoIis, MN Internship :: Hennepin County MedicaI Center, MinneapoIis, MN MedicaI Degree :: University of Minnesota MedicaI SchooI, MinneapoIis, MN Graduate schooI :: MicrobioIogy, University of North Dakota, Grand Forks, ND BacheIor of Arts :: St. Mary's CoIIege, Winona, MN Member :: American MedicaI Association, American Society of Cataract and Refractive Surgery, Minnesota Academy of OphthaImoIogy, Minnesota MedicaI Association, Ramsey MedicaI Society Licensed :: Minnesota, Wisconsin CHRONOLOGY: On or about 12May2012 hDan A. Nichols, MD Board-Certified Ophthalmologist "I've had a long-time interest in perception and neuroscience going back to college. That combined with the powerful therapeutic potential of ophthalmic surgery is what interested me in this field. The eye is the most fascinating organ in the body. I'm still excited and amazed as I view the eye under the microscope. I also enjoy the broad range of people I meet each day in the office; everyone eventually needs eyecare. I am analytical and problem/solution-oriented. I hope to give my patients a clear understanding of their problem and how best to proceed. I have a strong academic background in science and research, and I believe I can help each patient understand the best solution to his or her problem based on current knowledge." Board-Certified:: American Board of Ophthalmology Fellowship:: Glaucoma, Wills Eye Hospital, Philadelphia, PA Residency:: Ophthalmology, University of Arizona, Tucson, AZ Ìnternship:: Ìnternal Medicine, Abbott-Northwestern Hospital Department of Medicine, Minneapolis, MN Medical Degree:: University of Minnesota Medical School, Minneapolis, MN Bachelor of Arts:: Child Psychology, University of Minnesota, Minneapolis, MN Member:: Association for Research in Vision and Ophthalmology, Spaeth Glaucoma Fellow Society, Ramsey Medical Society, American Society of Cataract & Refractive Surgery Adjunct Clinical Professor:: University of Minnesota, Department of Ophthalmology Licensed:: Minnesota, Wisconsin Author & Lecturer http://www.stpauIeye.com/ Diane S Tanabe | Lufkin Eye CIinic PA | St. PauI, MN | AIIina HeaIth wellness.allinahealth.org/providers/3261Cached Diane S Tanabe, MD has sepecial interests in glaucoma, eye implants, eye lid problems, cataract surgery, blepharoplasty, blepharospasm, cornea, infectious ... Then Diane S. Tanabe who does not do Cataract , GoogIe Search Page 2 of 4 Thursday, March 14, 2013 AOL: Sharon4Anderson pubIish's otherwise. Surgery Did Lazer Diane Tanabe Lufkin Eye Clinic, P.A. S t. Paul 292-8200 From: [email protected] To: [email protected] Sent: 5/8/2012 5:29:33 P.M. Central Daylight Time Subj: University of Minnesota Concerns Hello Sharon Ì attempted to leave you a voicemail today on your home phone, but regrettably Ì may have been cut off. Ì wanted to introduce myself to you as the Patient Relations Manager for UMPhysicians. Ì understand from speaking to Cathy and Jody in our Opthamology clinic that you have expressed some concerns to them. Ì wanted to let you know that the best outlet for those concerns is through my department. Ì would like to request that you write a letter outlining your concerns to me and send it via email or letter to the address listed at the bottom of this email. Once receiving your letter, Ì will look into the concerns and provide you a response. Please know that the best way to schedule and cancel appointments for the Opthamology clinic is through their scheduling line. The emails to the Opthamology staff are not the appropriate avenue to schedule, change or express your concerns in the future. Thank you and Ì look forward to hearing from you. Esther Esther Lisak, MBA Manager of Patient ReIations University of Minnesota Physicians Mayo MaiI Code 88 Office: Mayo B-374 420 DeIaware St. SE MinneapoIis, MN 55455 [email protected] (612)626-5268 direct (612) 626-9323 fax (612)899-9371 pager **CONFÌDENTÌALÌTY NOTÌCE** DO NOT READ THÌS EMAÌL ÌF YOU ARE NOT THE ÌNTENDED RECÌPÌENT. The information in this email may contain confidential and/or privileged material. Ìf you are not the intended recipient, your review, forwarding, copying, distribution, or any other use or disclosure of any information in this email is prohibited. Ìf you received this email in error, please destroy and delete this message from any computer and contact us immediately by return email. Page 3 of 4 Thursday, March 14, 2013 AOL: Sharon4Anderson [email protected] AttorneyProSe_Private AG, ECF 65913 Pacer:sa1299 TeI: 651-776-5835 HEALTH CARE Candidate MN Attorney GeneraI www.sharon4mnag.bIogspot.com 2014 2012Senate64 www.sharonsenate64.bIogspot.com http://sharon4anderson.wordpress.com/2012/04/14/judiciaI-corruption- _sharonscarreIIaanderson_IawIess-america/http://www.pacificIegaI.org/document.doc? id=608&utm_source=Sentry+-+3%2F21%2F12+HeaIthcare&utm_campaign=3-21- 12+HeaIthcare+SENTRY&utm_medium=emaiIhttp://sbIog.s3.amazonaws.com/wp- content/upIoads/2012/01/10-1032-bsac-Massachusetts.pdfhttp://sharon-mn- ecf.bIogspot.com/2007/03/foia-06cv-permission- to.htmIhttp://mpIs.startribune.com/news/metro/eIections/profiIes/26222.htmIhttp://www.angeIfire.com/pIanet/andersonadvocates/P http://forums.e-democracy.org/groups/stpaul-issues/files/f/900-2007-02-27T034409Z/WritProA06- 1150_30Jun06.pdfhttp://sharon4anderson.wordpress.com/2009/09/23/google-lawmen-cases-mn- 62cv09-1163/ POA http://www.angeIfire.com/mn3/andersonadvocates/2006water/PDFcorr/SADPA4172006.pdfhttp://wethepeopIeusa.ning.com/profiIe/SharonScarre www.twitter.com/sharon4anderson www.taxthemax.bIogspot.com www.documento.com/sharon4anderson www.sIideshare.com/sharon4anderson Page 4 of 4 Thursday, March 14, 2013 AOL: Sharon4Anderson